Assessment of Chimpanzee Adenovirus Serotype 63 Neutralizing Antibodies Prior to Evaluation of a Candidate Malaria Vaccine Regimen Based on Viral Vectors

Prior to a chimpanzee adenovirus-based (ChAd63) malarial vaccine trial, sera were collected to assess ChAd63-specific neutralizing antibody titers in Banfora (Burkina Faso). The low neutralizing antibody titers reported in both adults and children (median titers, 139.1 and 35.0, respectively) are en...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Nébié, Issa, Edwards, Nick J., Tiono, Alfred B., Ewer, Katie J., Sanou, Guillaume S., Soulama, Issiaka, Sanon, Souleymane, Diarra, Amidou, Yaro, Jean Baptiste, Kangoye, David, Imoukhuede, Egeruan B., Hill, Adrian V. S., Sirima, Sodiomon B.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2014
Teme:
Vaccines
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4054245/
https://ncbi.nlm.nih.gov/pubmed/24739980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00723-13
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items